发明授权
US4619942A Inhibition of Respiratory Syncytial virus-induced cell fusion by amidino
compounds
失效
通过脒基化合物抑制呼吸道合胞病毒诱导的细胞融合
- 专利标题: Inhibition of Respiratory Syncytial virus-induced cell fusion by amidino compounds
- 专利标题(中): 通过脒基化合物抑制呼吸道合胞病毒诱导的细胞融合
-
申请号: US521084申请日: 1983-08-08
-
公开(公告)号: US4619942A公开(公告)日: 1986-10-28
- 发明人: Richard R. Tidwell , Edward J. Dubovi , Joachim D. Geratz
- 申请人: Richard R. Tidwell , Edward J. Dubovi , Joachim D. Geratz
- 申请人地址: NC Chapel Hill
- 专利权人: University of North Carolina
- 当前专利权人: University of North Carolina
- 当前专利权人地址: NC Chapel Hill
- 主分类号: A61K31/155
- IPC分类号: A61K31/155 ; A61K31/34 ; A61K31/40 ; A61K31/415 ; A61K31/405
摘要:
A number of aromatic mono- and bis-amidines are capable of blocking cell fusion induced by Respiratory Syncytial (RS) virus. Suitable amidino compounds include those selected from the group consisting of 1-4-di(4-amidinophenoxy)-2-butanol; bis(5-amidino-2-benzimidazolyl)methane; 1,2-bis(5-amidino-2-benzimidazolyl)ethane; 5-amidino-indole; 5-amidinobenzimidazole, 5-amidino-1-methylindole and 5-amidino-1-(4-amidinobenzyl)indole. The most powerful of the compounds, bis(5-amidino-2-benzimidazolyl)methane (BABIM), is able to achieve complete suppression of syncytium formation at a concentration of 1 .mu.M. Inhibition occurs in RS virus-infected Hep-2 cells as well as CV-1 cells. BABIM also causes a significant retardation of RS virus penetration, but does not interfere with adsorption. Addition of the amidines after the penetration of RS virus does not affect single cycle yields. The compounds may be used in the prophylactic control of RS virus in man.
公开/授权文献
- US5574431A Deactivateable security tag 公开/授权日:1996-11-12
信息查询